Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Roselle in Patients With Grade 1 Essential Hypertension: A Phase III, Randomized, Double-Blind, Double-Dummy, Active-Controlled Clinical Trial

NCT06141200 is registered in ClinicalTrials.gov with Natural Wellness Egypt as lead sponsor.

NCT NCT06141200
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06141200 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Roselle in Patients With Grade 1 Essential Hypertension: A Phase III, Randomized, Double-Blind, Double-Dummy, Active-Controlled Clinical Trial
Lead sponsor
Natural Wellness Egypt
Phase
Phase 3
Overall status
Unknown status
Start date
March 31, 2024
Completion date
April 30, 2025
Enrollment
286 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

essential hypertension